Abstract:The leading cause of death in the United States is cardiovascular disease, regardless of gender. Women will more often have angina preceding their first myocardial infarct, but have more unrecognized infarctions than men. Women will be older, have more concomitant disease and present later in the course of their acute myocardial infarction. Although myocardial infarction may have similar clinical presentations in men and women, there are some important differences such as an increased incidence of non Q-wave m… Show more
“…Therefore, physiological levels of estrogen in normotensive animals seem not to exert any protective or deleterious effect. In humans, female gender is associated with worse prognosis in acute coronary syndromes [8,9]. Our data suggest that differences in co-morbidity and other factors (e.g.…”
Section: Gender Difference In I/r Injury In Normotensive Ratsmentioning
confidence: 73%
“…Female gender is also associated with greater susceptibility to acute ischemic syndromes [8]. Data from the US National Registry of Myocardial Infarction clearly indicate that there is a gender-based difference in mortality: among patients with less than 50 years of age, mortality rate for women is twice that for men [9].…”
In the pressure overload model of the Dahl salt-sensitive rat, female gender is associated with a more pronounced concentric hypertrophy, whereas male hearts develop a more eccentric type of remodeling. Although present at baseline, after ischemia/reperfusion systolic function is gender-independent but more determined by hypertrophy. In contrast, diastolic function is gender-dependent and aggravated by hypertrophy, leading to pronounced diastolic dysfunction. We can conclude that in the malignant setting of demand ischemia/reperfusion gender differences in hypertrophied hearts are unmasked: female hypertrophied hearts are more susceptible to ischemia/reperfusion than males. To determine whether in female hypertensive patients with acute coronary syndromes, diastolic dysfunction could contribute to the worse clinical course, further experimental and clinical studies are needed.
“…Therefore, physiological levels of estrogen in normotensive animals seem not to exert any protective or deleterious effect. In humans, female gender is associated with worse prognosis in acute coronary syndromes [8,9]. Our data suggest that differences in co-morbidity and other factors (e.g.…”
Section: Gender Difference In I/r Injury In Normotensive Ratsmentioning
confidence: 73%
“…Female gender is also associated with greater susceptibility to acute ischemic syndromes [8]. Data from the US National Registry of Myocardial Infarction clearly indicate that there is a gender-based difference in mortality: among patients with less than 50 years of age, mortality rate for women is twice that for men [9].…”
In the pressure overload model of the Dahl salt-sensitive rat, female gender is associated with a more pronounced concentric hypertrophy, whereas male hearts develop a more eccentric type of remodeling. Although present at baseline, after ischemia/reperfusion systolic function is gender-independent but more determined by hypertrophy. In contrast, diastolic function is gender-dependent and aggravated by hypertrophy, leading to pronounced diastolic dysfunction. We can conclude that in the malignant setting of demand ischemia/reperfusion gender differences in hypertrophied hearts are unmasked: female hypertrophied hearts are more susceptible to ischemia/reperfusion than males. To determine whether in female hypertensive patients with acute coronary syndromes, diastolic dysfunction could contribute to the worse clinical course, further experimental and clinical studies are needed.
“…Because risk factors for ischaemic heart and CVD may vary according to gender,21 22 men and women were analysed separately. Age was included in the background variables as a confounder.…”
In this prospective population-based sample, childhood adversities were associated with a significantly increased risk of objectively verified cardiovascular disease, especially among women but to a lesser extent among men. More studies with prospective settings are needed to confirm the association and possible mechanisms.
“…(2) Although men are more likely to have episodes of myocardial infarction (MI), women who do suffer an episode of MI are more likely to have a second MI, develop heart failure, or suffer subsequent sudden cardiac death. (3) Increasing age, lipid abnormalities, high blood pressure, obesity, DM and smoking are major risk factors for CVDs in both genders. (4) Data from the INTERHEART study indicates that the lower prevalence of acute coronary syndrome (ACS) among women of younger ages (i.e.…”
INTRODUCTIONThis study aimed to examine age-and gender-related differences in the comorbidities, drug utilisation and adverse drug reaction (ADR) patterns of patients admitted to a coronary care unit (CCU).
MeThODsThe present study was a retrospective cohort study. Two trained physicians independently reviewed the case records of CCU patients over a period of one year (Jan-Dec 2008). The demographic, clinical, and drug prescription data of the patients were analysed according to age group (18-59 years vs ≥ 60 years) and gender.ResUlTs A total of 574 patients were admitted to the CCU during the study period. Of these 574 patients, 65.2%were male, and 48.4% were ≥ 60 years old. No significant gender-based differences were found for the prescription of cardiovascular and non-cardiovascular drugs, and ADR patterns (p > 0.05). Male patients aged ≥ 60 years were found to have a higher rate of polypharmacy than those aged 18-59 years (p = 0.001). The duration of hospital stay was longer in male than female patients (p = 0.008), and the duration of CCU stay was longer for male patients aged ≥ 60 years than males aged 18-59 years (p = 0.013). Compared to patients aged 18-59 years, a greater number of patients aged ≥ 60 years were prescribed cardiovascular (p = 0.006) and non-cardiovascular drugs (p = 0.015). Patients aged ≥ 60 years also had a higher rate of polypharmacy (p = 0.001) and ADRs (p = 0.013), and a longer duration of CCU stay (p = 0.013). Renal (p = 0.047) and cutaneous (p = 0.003) ADRs were found to be more common in patients aged ≥ 60 years.
CONClUsIONNo major gender-related differences were observed in the prescription, drug utilisation and ADR patterns of our study cohort. Higher drug utilisation, ADR rates, and longer duration of CCU stay were noted in patients aged ≥ 60 years.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.